
RESMED INC
RMDNYSETrading Snapshot
- Day Range
- $375.42 β $386.66
- 52-Week Range
- $180.27 β $293.81
- Volume
- $1.72B
- Avg Volume
- $2.12B
- Shares Outstanding
- 145.1M
- Next Earnings
- Oct 26, 2026
Fundamentals Snapshot
- Annual Revenue
- $5.65B
- Last Q Revenue
- $1.46B
- P/E Ratio
- 20.9
- P/S Ratio
- 5.6x
- EPS (TTM)
- $10.44
- Dividend Yield
- 1.10%
Why Investors Own RMD
- βHigh-growth profile β revenue up +32.9% YoY with expanding US Equity exposure.
- βHealthy economics β 49% gross margin and 6% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About RESMED INC
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
RESMED INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift RMD price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
RESMED INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.